Contact
Attralus Bulletin
News, Press Releases, & Other Media
About Amyloidosis
Amyloidosis
Science & Pipeline
Leadership
TEam
Bulletin
Contact
all posts
All Posts
Press Releases
Press Releases
In the News
In the News
Note: Attralus, Inc. was formally known as Aurora Bio, Inc.
In the News
September 14, 2020
Attralus Eyes Further Work on Therapeutic Candidates with New Funding
www.biospace.com
Note: Source article is behind a pay wall
Note: Source article is only available to members, but subscription is free
Read More
Read on
www.biospace.com
In the News
September 14, 2020
Attralus Raises $25 Million to Transform Treatment for Patients with Systemic Amyloidosis
globalgenes.org
Note: Source article is behind a pay wall
Note: Source article is only available to members, but subscription is free
Read More
Read on
globalgenes.org
In the News
September 14, 2020
The Crunchbase News Briefing: Mon., Sept. 14
news.crunchbase.com
Note: Source article is behind a pay wall
Note: Source article is only available to members, but subscription is free
Read More
Read on
news.crunchbase.com
In the News
September 14, 2020
Attralus Raises $25M in Series A Financing
finsmes.com
Note: Source article is behind a pay wall
Note: Source article is only available to members, but subscription is free
Read More
Read on
finsmes.com
In the News
September 14, 2020
Attralus Secures $25M Series A to Diagnose and Treat Amyloidosis
timmermanreport.com
Note: Source article is behind a pay wall
Note: Source article is only available to members, but subscription is free
Read More
Read on
timmermanreport.com
In the News
September 14, 2020
Attralus debuts with $25M series A to tackle systemic amyloidosis
biocentury.com
Note: Source article is behind a pay wall
Note: Source article is only available to members, but subscription is free
Read More
Read on
biocentury.com
Get in Touch
Partnership, Careers, Press, OR PATIENT Inquiries
Name*
COMPANY
Email*
PHONE
sUBJECT*
Message*
Thank you
Your message has been received!
We will reply as soon as possible.
Oops! Something went wrong while submitting the form.
our apologies
TABLET & MOBILE EXPERIENCES
ARE STILL UNDER CONSTRUCTION
Please view on a desktop or laptop computer.
